Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria

Intervention Study Clinical Trial

Official title:

Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03182972
• Other study ID #: MR/UCH/FMC/73247
• Status: Completed
• Phase: N/A
• Start date: August 2, 2016
• Est. completion date: April 30, 2019

Study information

• Verified date: November 2022
• Source: University of Ibadan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered

Description:

Background information garnering will be done among the pharmacists in the two selected hospitals to collect data on current practice of medication reconciliation. Focus group discussion will be done in the intervention group so as to identify peculiarities of their practice and to provide the best approach to carrying out the intervention. Diabetes and hypertensive patients in medical outpatient clinic will be interviewed in order to assess current practice of medication reconciliation.

Intervention will be channeled towards addressing gaps discovered. University College Hospital, Ibadan, Oyo State will be the intervention group, while University of Ilorin Teaching Hospital, Kwara State will be the control group.

The effect of the intervention will be measured over time to ensure that medication reconciliation is implemented in the selected institutions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: April 30, 2019
• Est. primary completion date: April 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participant has diabetes and/or hypertension

• Registered pharmacists in the selected institutions

Exclusion Criteria:

• Participants that are neither diabetic nor hypertensive

• Unregistered pharmacists in the selected institutions

Related Conditions & MeSH terms

• Intervention Study

Intervention

Other:
• Medication reconciliation
Pre-post intervention

Locations

Country	Name	City	State
Nigeria	University College Hospital	Ibadan	Oyo
Nigeria	University of Ilorin Teaching Hospital	Ilorin	Kwara

Sponsors (1)

Lead Sponsor	Collaborator
University of Ibadan

Country where clinical trial is conducted

Nigeria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Medication reconciliation: Percentage unreconciled medications	Percentage unreconciled medications	3 months